Combining the oncolytic peptide LTX-315 with doxorubicin demonstrates therapeutic potential in a triple-negative breast cancer model.

Combining the oncolytic peptide LTX-315 with doxorubicin demonstrates therapeutic potential in a triple-negative breast cancer model. — المؤلف: Camilio, Ketil A — Breast cancer research : BCR 20190722

المؤلف

Camilio, Ketil A

النشر

Breast cancer research : BCR 20190722

الوصف

9 p.

الموضوعات

Animals؛ Antineoplastic Combined Chemotherapy Protocols؛ CD8-Positive T-Lymphocytes؛ Cell Line, Tumor؛ Disease Models, Animal؛ Doxorubicin؛ Drug Screening Assays, Antitumor؛ Female